2-deoxyglucose AUC | *None* | | 0 to Infinity | *None*
| |

acetoacetate oxidation | ACT OX | (µMol/min/g) | -Infinity to Infinity | *None*
| |

Activity (hourly) | Activity-hourly | (beam breaks/h) | 0 to Infinity | U Mass - Energy balance – food intake, energy expenditure, physical activity | |

Activity 24h (total vertical z-axis) | Activity 24h total z | (beam breaks/24h) | -Infinity to Infinity | *None*
| |

Activity 24h (total x-axis) | Activity 24h total x | (beam breaks/24h) | -Infinity to Infinity | *None*
| |

Activity 24h (total) | Activity 24h (total) | (beam breaks/24h) | 0 to Infinity | U Mass - Energy balance – food intake, energy expenditure, physical activity | |

Activity 24h (x-ambulatory) | Activity 24h (x-amb) | (beam breaks/24h) | -Infinity to Infinity | *None*
| |

adenosine diphosphate | adp | | -Infinity to Infinity | *None*
| |

adenosine monophosphate | AMP | | -Infinity to Infinity | *None*
| |

adenosine triphosphate | *None* | | -Infinity to Infinity | *None*
| |

adiponectin | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

adiponectin, High Molecular Weight | adiponectin HMW | | 0 to 100 | *None*
| |

adiponectin, total | adiponectin total | (µg/ml) | 0 to 100 | *None*
| |

Adrenocorticotropic hormone | ACTH | (pg/ml) | 0 to Infinity | *None*
| |

Age | *None* | (w) | 0 to 1092 | *None*
| |

Akt, phosphorylated | Akt phosphorylated | (AU) | 0 to 10000 | *None*
| |

Akt, total | Akt total | (AU) | 0 to 10000 | *None*
| |

alanine | *None* | | 0 to Infinity | *None*
| |

alanine aminotransferase | ALT | (U/L) | 0 to Infinity | *None*
| |

Alanine transaminase, blood | *None* | | 0 to Infinity | U Mass - Alanine Transferase | |

albumin | *None* | (g/dL) | -Infinity to Infinity | *None*
| |

albumin, blood | *None* | | 0 to Infinity | *None*
| |

alkaline phosphatase | ALP | (U/L) | 0 to Infinity | *None*
| |

alkaline phosphatase, blood | *None* | | 0 to Infinity | *None*
| |

alpha ketoglutarate glutamate exchange rate | Vx | (µMol/min/g) | -Infinity to Infinity | *None*
| |

alternating triplets - percent | % triplets | (%) | 0 to 100 | UC Davis - Y-Maze | |

amino acids, branched-chain | *None* | | 0 to Infinity | *None*
| |

amino acids, essential | *None* | | 0 to Infinity | *None*
| |

amino acids, gluconeogenic | *None* | (U/L) | -Infinity to Infinity | *None*
| |

amino acids, glyconeogenic | glyconeogenic AA | | 0 to Infinity | *None*
| |

amino acids, nonessential | *None* | | 0 to Infinity | *None*
| |

ammonia | ammonia | (µmol/l) | -Infinity to Infinity | *None*
| |

anaplerosis | *None* | (µMol/min/g) | -Infinity to Infinity | *None*
| |

Angiotensin II | Angiotensin II | (ng/ml) | 0 to 1000 | *None*
| |

antibody | *None* | | -Infinity to Infinity | *None*
| |

antigen | *None* | | -Infinity to Infinity | *None*
| |

Aortic atherosclerosis area, abdominal | *None* | (%) | -Infinity to Infinity | *None*
| |

Aortic atherosclerosis area, thoracic | *None* | (%) | -Infinity to Infinity | *None*
| |

Aortic atherosclerosis area, total | *None* | (%) | -Infinity to Infinity | *None*
| |

aortic diameter, abdominal | *None* | (mm) | -Infinity to Infinity | *None*
| |

aortic lesion complexity index | LCI | | -Infinity to Infinity | *None*
| |

aortic pressure, mean | *None* | (mmHg) | -Infinity to Infinity | *None*
| |

apolipoprotein A | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

apolipoprotein B | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

apolipoprotein C3 | ApoC3 | (mg/dL) | 0 to 800 | *None*
| |

aspartate | *None* | | 0 to Infinity | *None*
| |

aspartate aminotransferase | AST | (U/L) | 0 to Infinity | *None*
| |

Assay Respiratory Control | RC | | -Infinity to Infinity | *None*
| |

average aortic lesion area | AALA | (µm²) | 0 to Infinity | *None*
| |

average clamp glucose | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

average glucose infusion rate | *None* | (mg/kg/min) | -Infinity to Infinity | *None*
| |

beta-hydroxybutyrate | *None* | (µmol/l) | -Infinity to Infinity | *None*
| |

beta-oxidation index | b-Ox index | (µMol/min/g) | -Infinity to Infinity | *None*
| |

bicarbonate | *None* | (mEq/L) | -Infinity to Infinity | *None*
| |

bilirubin | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

bilirubin, direct | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

bilirubin, Total | total bilirubin | (mg/dL) | 0 to Infinity | *None*
| |

blood flow, % | *None* | (%) | -Infinity to Infinity | *None*
| |

blood pressure, mean arterial | *None* | (mmHg) | -Infinity to Infinity | *None*
| |

blood pressure: diastole | dBP | (mmHg) | 0 to Infinity | Phenotypic Characterization of the Working Heart | |

blood pressure: mean arterial | aBP | (mmHg) | -Infinity to Infinity | *None*
| |

blood pressure: systole | sBP | (mmHg) | 0 to Infinity | Phenotypic Characterization of the Working Heart | |

body mass | W rodent | (g) | 0 to 100 | *None*
| |

body water | body fluid | (g) | -Infinity to Infinity | *None*
| |

body water, absolute amount | *None* | (g) | -Infinity to Infinity | *None*
| |

body water, free | free water | (g) | -Infinity to Infinity | *None*
| |

bone area | bone area | (cm²) | -Infinity to Infinity | *None*
| |

bone mineral content | BMC | (g) | -Infinity to Infinity | *None*
| |

bone mineral density | BMD | (g/cm²) | -Infinity to Infinity | *None*
| |

Bout Distance, Average | Avg Bout Distance | (m/bout) | 0 to 500 | *None*
| |

Bout Time, Average | Avg Bout Time | (min/bout) | 0 to 10 | *None*
| |

Bouts | Bouts | (unitless) | 0 to 1000 | *None*
| |

brain mass | brain wt | (g) | 0 to 3 | *None*
| |

C-peptide | C-peptide | (ng/ml) | -Infinity to Infinity | *None*
| |

c-reactive protein | CRP | (ng/ml) | 0 to 25000 | *None*
| |

calcium | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

calcium, blood | *None* | (mg/dL) | 0 to Infinity | *None*
| |

calcium, urine | urine calcium | (mg/dL) | 1 to 15 | *None*
| |

carbon dioxide production | VCO2 | (CO2/kg/hr) | -Infinity to Infinity | *None*
| |

carbon dioxide production Dark Period | VCO2-D | (CO2/kg/hr) | -Infinity to Infinity | *None*
| |

carbon dioxide production Light Period | VCO2-L | (CO2/kg/hr) | -Infinity to Infinity | *None*
| |

carbon dioxide, blood | *None* | | 0 to Infinity | *None*
| |

cardiac ejection fraction | *None* | (%) | 0 to 100 | *None*
| |

cardiac function, intraventricular pressure: diastole | *None* | (mmHg) | -Infinity to Infinity | *None*
| |

cardiac function, intraventricular pressure: end diastole | *None* | (mmHg) | -Infinity to Infinity | *None*
| |

cardiac function, intraventricular pressure: systole | *None* | (mmHg) | -Infinity to Infinity | *None*
| |

cardiac output | *None* | | 0 to Infinity | *None*
| |

cardiac venous return | *None* | (ml/min) | -Infinity to Infinity | *None*
| |

Catalase Activity | CAT Activity | (nmol/min/ml) | 0 to 5000 | *None*
| |

Catalase Activity - protein | CAT Activity - prot | (nmol/min/mg protein) | 0 to 5000 | *None*
| |

CCL11 | Eotaxin | (pg/ml) | -Infinity to Infinity | *None*
| |

CCL21 | Exodus-2 | (pg/ml) | 0 to Infinity | *None*
| |

chloride concentration | *None* | (U/kg) | -Infinity to Infinity | *None*
| |

chloride, blood | *None* | | 0 to Infinity | *None*
| |

chloride, urine | urine chloride | (µmol/l) | 0 to Infinity | *None*
| |

cholesterol | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

cholesterol concentration in low density lipoproteins | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

cholesterol concentration in very low density lipoproteins | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

cholesterol remaining in intestinal lumen | *None* | (%) | -Infinity to Infinity | *None*
| |

cholesterol remaining in intestinal lymph | *None* | (%) | -Infinity to Infinity | *None*
| |

cholesterol remaining in intestinal mucosa | *None* | (%) | -Infinity to Infinity | *None*
| |

Cholesterol transported in lymph | Cholesterol in lymph | (%) | -Infinity to Infinity | *None*
| |

cholesterol, CM, plasma | CM-cholesterol | (mg/dL) | 0 to 10000 | *None*
| |

cholesterol, fractional clearance rate | CHOL FCR | (min) | -Infinity to Infinity | *None*
| |

cholesterol, HDL | *None* | (%) | -Infinity to Infinity | *None*
| |

cholesterol, HDL (COBAS) | HDL-COBAS | (mg/dL) | 0 to Infinity | *None*
| |

cholesterol, HDL (UC) | HDL-UC | (mg/dL) | 0 to Infinity | Ultracentrifugal separation of VLDL, LDL and HDL | |

cholesterol, HDL, plasma | HDL-cholesterol | (mg/dL) | -Infinity to Infinity | *None*
| |

cholesterol, HDL, triglycerides, plasma | HDL-TG | (mg/dL) | -Infinity to Infinity | *None*
| |

Cholesterol, Hepatic Uptake | Hepatic CHOL uptake | (%) | -Infinity to Infinity | *None*
| |

cholesterol, LDL and VLDL | LDL/VLDL | (mg/dL) | 0 to 5000 | *None*
| |

cholesterol, LDL, plasma | LDL-cholesterol | (mg/dL) | -Infinity to Infinity | *None*
| |

cholesterol, newly synthesized | new cholesterol | (%) | 0 to 100 | *None*
| |

cholesterol, splenic uptake | Splenic CHOL uptake | (%) | -Infinity to Infinity | *None*
| |

cholesterol, TG-bound new | TG-bound cholesterol | (umol new/g tissue) | -Infinity to Infinity | *None*
| |

cholesterol, TG-bound total | TG-bound cholesterol | (umol total/g tissue) | -Infinity to Infinity | *None*
| |

cholesterol, tissue | cholesterol (tissue) | (mg/g tissue) | -Infinity to Infinity | *None*
| |

cholesterol, total | TC | (mg/dL) | 0 to Infinity | Lipid Profiles in Mice | |

cholesterol, vLDL, plasma | VLDL-cholesterol | (mg/dL) | -Infinity to Infinity | *None*
| |

cholesteryl ester fatty acids | *None* | (%) | 0 to 100 | *None*
| |

cholesteryl ester in chylomicrons | CE-CM | (% wt/wt) | -Infinity to Infinity | *None*
| |

cholesteryl esters | *None* | (µg/mg) | 0 to Infinity | *None*
| |

chylomicrons | *None* | (%) | -Infinity to Infinity | *None*
| |

citrate flux rate | *None* | (µMol/min/g) | -Infinity to Infinity | *None*
| |

citrate synthase flux rate | citrate synthase FR | | -Infinity to Infinity | *None*
| |

CoA ester, C16:0 | *None* | (nmol/g-tissue) | -Infinity to Infinity | *None*
| |

CoA ester, C16:1 | *None* | (nmol/g-tissue) | -Infinity to Infinity | *None*
| |

CoA ester, C18:0 | *None* | (nmol/g-tissue) | -Infinity to Infinity | *None*
| |

CoA ester, C18:1 | *None* | (nmol/g-tissue) | -Infinity to Infinity | *None*
| |

CoA ester, C18:2 | *None* | (nmol/g-tissue) | -Infinity to Infinity | *None*
| |

CoA ester, C18:3 | *None* | (nmol/g-tissue) | -Infinity to Infinity | *None*
| |

CoA ester, total | TotalCoA | (nmol/g-tissue) | 0 to Infinity | *None*
| |

CoA esters, long-chain | *None* | (nmole) | -Infinity to Infinity | *None*
| |

Complexes | *None* | (bpm) | 0 to Infinity | *None*
| |

corticosterone | *None* | (ng/ml) | -Infinity to Infinity | *None*
| |

corticosterone, plasma, arterial | *None* | (µg/mg) | 0 to Infinity | *None*
| |

creatine kinase | creatine kinase | (U/L) | 0 to Infinity | *None*
| |

creatinine, blood | blood creatinine | (mg/dL) | 0 to Infinity | *None*
| |

creatinine, plasma | plasma cre | (mg/dL) | 0 to Infinity | *None*
| |

creatinine, serum | SCR | (mg/dL) | 0 to Infinity | *None*
| |

creatinine, urine (Exocell Picric Acid method) | ucreat | (mg/dL) | 0 to Infinity | *None*
| |

creatinine, urine (spot) | ucreatinine-spot | (mg/dL) | -Infinity to Infinity | *None*
| |

creatinine, urine, 24h (HPLC) | UCreat-HPLC | (mg/dL) | -Infinity to Infinity | *None*
| |

CX3CL1 | Fractalkine | (pg/ml) | 0 to Infinity | *None*
| |

diacyglycerols | *None* | (µg/mg) | 0 to Infinity | *None*
| |

diacylglycerol fatty acids | *None* | (%) | 0 to 100 | *None*
| |

Distance run | Distance run | (m) | 0 to 20000 | *None*
| |

DR | D | | -Infinity to Infinity | *None*
| |

duration of recording | *None* | (min) | 0 to Infinity | *None*
| |

Duration run | Duration run | (min) | 0 to 720 | *None*
| |

eating rate, average | avg eating rate | (g/min) | 0 to Infinity | *None*
| |

eating rate, dark | dark-eating rate | (g/min) | 0 to Infinity | *None*
| |

eating rate, light | light-eating rate | (g/min) | 0 to Infinity | *None*
| |

EKG-Beginning to end of QRS complex | EKG-QRS | (msec) | -Infinity to Infinity | *None*
| |

EKG-Interval between R-waves | EKG-RR | (msec) | -Infinity to Infinity | *None*
| |

EKG-Interval between the peak of P-wave to Q-wave | EKG-PQ | (msec) | -Infinity to Infinity | *None*
| |

EKG-Interval between the peak of P-wave to R-wave | EKG-PR | (msec) | -Infinity to Infinity | *None*
| |

EKG-Interval between the peak of Q-wave to end of T-wave | EKG-QT | (msec) | -Infinity to Infinity | *None*
| |

EKG-Interval between the peak of S-wave to end of T-wave | EKG-ST | (msec) | -Infinity to Infinity | *None*
| |

EKG-Rate-corrected QT | EKG-QTc | (msec) | -Infinity to Infinity | *None*
| |

endurance time | *None* | (min) | 0 to Infinity | *None*
| |

energy expenditure | *None* | (kcal/hr/kg) | -Infinity to Infinity | *None*
| |

energy expenditure, 30 min exercise | *None* | | 0 to Infinity | *None*
| |

energy expenditure, basal | *None* | | 0 to Infinity | *None*
| |

energy expenditure, exhaustion | *None* | | 0 to Infinity | *None*
| |

energy expenditure, maximum | *None* | | 0 to Infinity | *None*
| |

energy intake (24 hr) | *None* | (Kcal/day) | -Infinity to Infinity | *None*
| |

energy intake (avg 24 hr) | energy intake avg 24 | (Kcal/day) | -Infinity to Infinity | *None*
| |

energy intake (Dark Period) | energy intake - dark | (Kcal/12h) | -Infinity to Infinity | *None*
| |

energy intake (Light Period) | food intake - light | (g/12h) | 0 to Infinity | *None*
| |

energy intake (Ligth Period) | energy intake -light | (Kcal/12h) | -Infinity to Infinity | *None*
| |

epinephrine, plasma, arterial | *None* | | 0 to Infinity | *None*
| |

Erythropoietin | EPO | (pg/ml) | 0 to Infinity | *None*
| |

Estradiol | Estradiol | (pg/ml) | 0 to Infinity | *None*
| |

exploratory activity | *None* | | 0 to Infinity | *None*
| |

fat absorbtion, dietary | *None* | (%) | -Infinity to Infinity | *None*
| |

fat body mass | *None* | (g) | 0 to Infinity | *None*
| |

fat tissue mass | *None* | (g) | -Infinity to Infinity | *None*
| |

fat tissue, % | % body fat | (%) | 0 to 100 | *None*
| |

fat tissue, brown | BAT wt | (g) | 0 to 7 | *None*
| |

fat tissue, epidymal | epidymal fat wt | (g) | 0 to 7 | *None*
| |

fat tissue, mesenteric | Mesenteric Fat Wt | (g) | 0 to 7 | *None*
| |

fat tissue, periovarian | PFD wt | (g) | 0 to 7 | *None*
| |

fat tissue, retroperitoneal | retroperitoneal fat | (g) | 0 to 7 | *None*
| |

fat tissue, subcutaneous | subcutaneous fat wt | (g) | 0 to 7 | *None*
| |

Fecal Output | *None* | (g) | -Infinity to Infinity | *None*
| |

Fibroblast growth factor 21 | FGF-21 | (pg/ml) | 0 to 50000 | *None*
| |

FITC-Dextran 4000 (FD4) flux | FD4 flux | (ng/cm2/h) | 0 to Infinity | UC Davis - Ex vivo assessment of barrier function-gut permeability | |

food intake | food intake | (g/day) | 0 to Infinity | *None*
| |

food intake (Dark Period) | food intake - dark | (g/12h) | -Infinity to Infinity | *None*
| |

food intake to body weight ratio | food intake/bw | | 0 to Infinity | *None*
| |

fractional shortening | *None* | | 0 to Infinity | Echocardiography: Mouse | |

free fatty acids, tissues | FFA tissue | (mEq/g tissue) | 0 to 100 | *None*
| |

GABA and glutamate | *None* | | 0 to Infinity | *None*
| |

Gamma-glutamyl Transpeptidase | GGT | (U/L) | 0 to 50 | *None*
| |

ghrelin, active | ghrelin active | (pg/ml) | 0 to 1000 | *None*
| |

ghrelin, total | ghrelin total | (pg/ml) | 0 to 10000 | *None*
| |

GIP | GIP | (ng/ml) | -Infinity to Infinity | *None*
| |

glomerular filtration rate | GFR | (ml/min) | -Infinity to Infinity | *None*
| |

glucagon | *None* | (pg/ml) | -Infinity to Infinity | *None*
| |

glucagon, plasma, arterial | *None* | | 0 to Infinity | *None*
| |

Glucagon-like peptide 1 | GLP-1 | (ng/ml) | -Infinity to Infinity | *None*
| |

glucagon-like peptide-1, active | GLP-1 active | (pg/ml) | 0 to 1000 | *None*
| |

glucagon-like peptide-1, total | GLP-1 total | (pg/ml) | 0 to 1000 | *None*
| |

gluconeogenesis | GNGtotal | (µMol/min/g) | -Infinity to Infinity | *None*
| |

gluconeogenesis from glycerol | GNGglycerol | (µMol/min/g) | -Infinity to Infinity | *None*
| |

gluconeogenesis from PEP | GNGpep | (µMol/min/g) | -Infinity to Infinity | *None*
| |

gluconeogenesis rate | *None* | (mg/kg/min) | 0 to Infinity | *None*
| |

glucose appearance, endogenous | *None* | | -Infinity to Infinity | *None*
| |

glucose infusion rate | *None* | | -Infinity to Infinity | *None*
| |

glucose infusion rates | *None* | (mg/kg/min) | 0 to Infinity | *None*
| |

glucose metabolic index, brain | *None* | | 0 to Infinity | *None*
| |

glucose metabolic index, diaphragm | *None* | | 0 to Infinity | *None*
| |

glucose metabolic index, gastrocnemius | *None* | | 0 to Infinity | *None*
| |

glucose metabolic index, heart | *None* | | -Infinity to Infinity | *None*
| |

glucose metabolic index, soleus | *None* | | 0 to Infinity | *None*
| |

glucose metabolic index, superficial vastus lateralis | *None* | | 0 to Infinity | *None*
| |

glucose oxidation | *None* | (µMol/min/g) | -Infinity to Infinity | *None*
| |

glucose production | *None* | (µMol/min/g) | -Infinity to Infinity | *None*
| |

glucose rate of appearance, endogenous | endo RA | (mg/kg/min) | 0 to Infinity | *None*
| |

glucose rate of disappearance | *None* | | -Infinity to Infinity | *None*
| |

glucose synthesis | *None* | (nmol/min/g) | -Infinity to Infinity | *None*
| |

glucose tolerance test (AUC) | GTT-AUC | (mg/dl*min) | 10000 to 100000 | *None*
| |

glucose turnover, whole body | *None* | (mg/kg/min) | -Infinity to Infinity | *None*
| |

glucose uptake | *None* | (nmol/min/g) | -Infinity to Infinity | Glucose uptake in isolated cardiomyocytes. | |

glucose uptake, basal - brain | BasalGU-brain | (dpm/mg) | 1 to 1000000 | *None*
| |

glucose uptake, basal - brown adipose tissue | BasalGU-BAT | (dpm/mg) | 1 to 1000000 | *None*
| |

glucose uptake, basal - gastrocnemius | BasalGU-gastrocnemiu | (dpm/mg) | 1 to 1000000 | *None*
| |

glucose uptake, basal - liver | BasalGU-liver | (dpm/mg) | 1 to 1000000 | *None*
| |

glucose uptake, basal - quadriceps | BasalGU-quadriceps | (dpm/mg) | 1 to 1000000 | *None*
| |

glucose uptake, basal - red blood cells | BasalGU-RBC | (dpm/ml) | 1 to 1000000 | *None*
| |

glucose uptake, basal - spleen | BasalGU-spleen | (dpm/mg) | 1 to 1000000 | *None*
| |

glucose uptake, basal - white adipose tissue | BasalGU-WAT | (dpm/mg) | 1 to 1000000 | *None*
| |

glucose uptake, brown fat | glucose uptake brown | (nmole/g/min) | 0 to Infinity | *None*
| |

glucose uptake, heart | glucose uptake heart | (nmole/g/min) | 0 to Infinity | *None*
| |

glucose uptake, muscle | glucose uptake muscl | (nmole/g/min) | 0 to Infinity | *None*
| |

glucose uptake, white adipose | glucose uptake white | (nmole/g/min) | 0 to Infinity | *None*
| |

glucose, arterial | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

glucose, basal | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

glucose, blood | blood glucose | (mg/dL) | 0 to Infinity | *None*
| |

glucose, blood, arterial | *None* | | -Infinity to Infinity | *None*
| |

glucose, clamp average | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

glucose, plasma | plasma glucose | (mg/dL) | 0 to Infinity | *None*
| |

glucose, rate of disappearance | Rd | (mg/kg/min) | -Infinity to Infinity | *None*
| |

glucose, urine | *None* | (mg/dL) | 0 to Infinity | *None*
| |

glutamate | *None* | | 0 to Infinity | *None*
| |

glutamine | *None* | | 0 to Infinity | *None*
| |

glutamine dehydrogenase | GLDH | (U/L) | 0 to Infinity | *None*
| |

glutamine rate of appearance in blood | *None* | | 0 to Infinity | *None*
| |

glutamine rate of disappearance in blood | *None* | | 0 to Infinity | *None*
| |

glutamine, blood, arterial | *None* | | 0 to Infinity | *None*
| |

Glutathione Peroxidase Activity | GP Activity | (nmol/min/ml) | 0 to 5000 | *None*
| |

Glutathione Peroxidase Activity - protein | GPA-protein | (nmol/min/mg protein) | 0 to 1000 | *None*
| |

Glutathione Reductase Activity | GR Activity | (nmol/min/ml) | 0 to 5000 | *None*
| |

Glutathione Reductase Activity - protein | GRA-protein | (nmol/min/mg protein) | 0 to 1000 | *None*
| |

glycerol | *None* | (µMol/min/g) | -Infinity to Infinity | *None*
| |

glycerol flux rate | glycerol FR | | -Infinity to Infinity | *None*
| |

glycerol fraction | glycerol fraction | | -Infinity to Infinity | *None*
| |

glycerol, plasma | *None* | (mg/dL) | 0 to 100 | *None*
| |

glycerol, TG-bound new | TG-bound glycerol ne | (umol new/g tissue) | -Infinity to Infinity | *None*
| |

glycerol, TG-bound total | TG-bound glycerol to | (umol total/g tissue) | -Infinity to Infinity | *None*
| |

glycerol, total labeled | glycerol total label | (%) | 0 to 100 | *None*
| |

glycine | *None* | | 0 to Infinity | *None*
| |

glycogen synthesis | *None* | (nmol/min/g) | -Infinity to Infinity | *None*
| |

glycogen concentration | glycogen conc | | 0 to Infinity | *None*
| |

glycogen flux rate | glycogen FR | | -Infinity to Infinity | *None*
| |

glycogen fraction | glycogen fraction | | -Infinity to Infinity | *None*
| |

glycogen, gastrocnemius | *None* | | -Infinity to Infinity | *None*
| |

glycogen, heart | *None* | | -Infinity to Infinity | *None*
| |

glycogen, liver | *None* | | 0 to Infinity | *None*
| |

glycogen, muscle | *None* | | -Infinity to Infinity | *None*
| |

glycogen, superficial vastus lateralis | *None* | | 0 to Infinity | *None*
| |

glycogen/lipid synthesis, whole body | *None* | (mg/kg/min) | -Infinity to Infinity | *None*
| |

glycogenolysis, rate | GLY | (µMol/min/g) | -Infinity to Infinity | *None*
| |

glycogenolytic rate | *None* | (mg/kg/min) | 0 to Infinity | *None*
| |

glycolysis | *None* | (nmol/min/g) | -Infinity to Infinity | *None*
| |

glycolysis, whole body | *None* | (mg/kg/min) | -Infinity to Infinity | *None*
| |

Granulocyte colony stimulating factor | G-CSF | (pg/ml) | -Infinity to Infinity | *None*
| |

Growth Hormone | GH | (ng/ml) | 0 to Infinity | *None*
| |

HbA1c | HbA1c | (%) | 0 to 100 | *None*
| |

heart mass | cardiac muscle weigh | (g) | 0 to 3 | *None*
| |

heart rate | HR | (bpm) | 0 to Infinity | Phenotypic Characterization of the Working Heart | |

heat | HEAT | (Kcal/hr) | -Infinity to Infinity | *None*
| |

heat (24hr) | heat - 24h | (Kcal/day) | -Infinity to Infinity | *None*
| |

heat (Dark Period) | HEAT-Dark | (Kcal/hr) | -Infinity to Infinity | *None*
| |

heat (Light Period) | HEAT-Light | (Kcal/hr) | -Infinity to Infinity | *None*
| |

hematocrit | Hct | | 0 to Infinity | *None*
| |

hematocrit, arterial | *None* | (%) | -Infinity to Infinity | *None*
| |

Hematocrit, HCT | *None* | (%) | 0 to 100 | *None*
| |

hepatic glucose production | HPG | (µMol/min/g) | -Infinity to Infinity | *None*
| |

hepatic glucose production, basal | *None* | (mg/kg/min) | -Infinity to Infinity | *None*
| |

Hepatic Glucose Production, clamp | *None* | (mg/kg/min) | -Infinity to Infinity | *None*
| |

hepatic insulin action | HIA | (%) | 0 to 100 | *None*
| |

Histidine | *None* | | 0 to Infinity | *None*
| |

Horseradish peroxidase (HRP) flux | HRP flux | (ng/cm2/h) | 0 to Infinity | UC Davis - Ex vivo assessment of barrier function-gut permeability | |

immunohistochemistry - BODIPY | IHC-BODIPY | (intensity (AU)) | 0 to Infinity | UC Davis - Immunohistochemistry BODIPY | |

immunohistochemistry - Factor VIII | IHC-Factor VIII | (density (AU)) | 0 to Infinity | UC Davis - Immunohistochemistry Factor VIII | |

immunohistochemistry - IBA1 | IHC-IBA1 | (density (AU)) | 0 to Infinity | UC Davis - Immunohistochemistry IBA1 | |

immunohistochemistry - Mitochondrial Marker | IHC-Mito Marker | (density (AU)) | 0 to Infinity | UC Davis - Immunohistochemistry Mitochondrial marker | |

Insulin 16.8 mM glucose | *None* | | 0 to Infinity | *None*
| |

Insulin 16.8 mM glucose + IBMX | *None* | | 0 to Infinity | *None*
| |

Insulin 5.6 mM glucose | *None* | | 0 to Infinity | *None*
| |

Insulin 5.6 mM glucose + tollbutamide | *None* | | 0 to Infinity | *None*
| |

insulin dose | *None* | (µMol/min/g) | -Infinity to Infinity | *None*
| |

insulin receptor substrate 1, phosphorylated | IRS-1 phosphorylated | (AU) | 0 to 10000 | *None*
| |

insulin receptor substrate 1, total | IRS-1 total | (AU) | 0 to 10000 | *None*
| |

insulin, arterial | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

insulin, basal | *None* | (ng/ml) | 0 to Infinity | *None*
| |

insulin, blood | *None* | (ng/dl) | 0 to Infinity | *None*
| |

insulin, clamp | *None* | (ng/ml) | 0 to Infinity | *None*
| |

insulin, experimental | *None* | | -Infinity to Infinity | *None*
| |

insulin, plasma | *None* | (pg/ml) | 5 to 500000 | *None*
| |

insulin, plasma, arterial | *None* | | 0 to Infinity | *None*
| |

insulin, serum | S Insulin | | 0 to Infinity | *None*
| |

Insulin-like Growth Factor-1 | IGF-1 | (ng/ml) | 0 to 1000 | *None*
| |

inter-meal interval, average | avg IMI | (sec) | 0 to Infinity | *None*
| |

inter-meal interval, average dark | avg dark-IMI | (sec) | 0 to Infinity | *None*
| |

inter-meal interval, average light | avg light-IMI | (sec) | 0 to Infinity | *None*
| |

Interferon gamma | IFNg | (pg/ml) | 0 to Infinity | *None*
| |

Interferon gamma-induced protein 10 (CXCL-10) | IP-10 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 1 alpha | IL-1a | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 1 beta | IL-1ß | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 10 | IL-10 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 12 (p40) | IL-12 (p40) | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 12 (p70) | IL-12 (p70) | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 13 | IL-13 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 15 | IL-15 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 16 | IL-16 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 17A | IL-17A | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 17E / Interleukin 25 | IL-17E/IL-25 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 2 | IL-2 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 20 | IL-20 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 21 | IL-21 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 22 | IL-22 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 23 | IL-23 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 27 | IL-27 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 28B | IL-28B | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 3 | IL-3 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 33 | IL-33 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 4 | IL-4 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 5 | IL-5 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 6 | IL-6 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 7 | IL-7 | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 8 homologue | KC | (pg/ml) | 0 to Infinity | *None*
| |

Interleukin 9 | IL-9 | (pg/ml) | 0 to Infinity | *None*
| |

Iron | Iron | (µg/dl) | 0 to 1000 | *None*
| |

isoleucine | *None* | | 0 to Infinity | *None*
| |

ketogenesis | ketogenesis | (µMol/min/g) | -Infinity to Infinity | *None*
| |

ketoisocaproic, blood, arterial | *None* | | 0 to Infinity | *None*
| |

ketones, urine | urine ketones | | -Infinity to Infinity | *None*
| |

Kf, brain | *None* | | 0 to Infinity | *None*
| |

Kf, diaphragm | *None* | | 0 to Infinity | *None*
| |

Kf, diaphragms | *None* | | 0 to Infinity | *None*
| |

Kf, gastrocnemius | *None* | | 0 to Infinity | *None*
| |

Kf, heart | *None* | | 0 to Infinity | *None*
| |

Kf, soleus | *None* | | 0 to Infinity | *None*
| |

Kf, superficial vastus laterlis | *None* | | 0 to Infinity | *None*
| |

Kg, adipose | *None* | (ml/100g/min) | 0 to Infinity | *None*
| |

Kg, brain | *None* | (ml/100g/min) | 0 to Infinity | *None*
| |

Kg, diaphragm | *None* | (ml/100g/min) | 0 to Infinity | *None*
| |

Kg, gastrocnemius | *None* | (ml/100g/min) | 0 to Infinity | *None*
| |

Kg, heart | *None* | (ml/100g/min) | 0 to Infinity | *None*
| |

Kg, soleus | *None* | (ml/100g/min) | 0 to Infinity | *None*
| |

Kg, superficial vastus lateralis | *None* | (ml/100g/min) | 0 to Infinity | *None*
| |

Kg, vastus lateralis | *None* | (ml/100g/min) | -Infinity to Infinity | *None*
| |

kidney glomerular size | GlomerularSize | (µm²) | -Infinity to Infinity | *None*
| |

kidney matrix area | kidney matrix area | (µm²) | -Infinity to Infinity | *None*
| |

kidney percent matrix | kidney percent matri | (%) | 0 to 100 | *None*
| |

kidney, long-axis area | *None* | (cm) | 0 to Infinity | *None*
| |

kidney, long-axis area, right | right kidney LAArea | (cm) | 0 to Infinity | *None*
| |

kidney, long-axis circle | *None* | (cm) | 0 to Infinity | *None*
| |

kidney, long-axis circle, right | right kidney LACircl | (cm) | 0 to Infinity | *None*
| |

kidney, long-axis HGT | *None* | (cm) | 0 to Infinity | *None*
| |

kidney, long-axis HGT, right | right kidney LAHGT | (cm) | 0 to Infinity | *None*
| |

kidney, long-axis LGT | *None* | (cm) | 0 to Infinity | *None*
| |

kidney, long-axis LGT, right | right kidney LALGT | (cm) | 0 to Infinity | *None*
| |

kidney, short-axis area, right | right kidney SAArea | (cm) | 0 to Infinity | *None*
| |

kidney, short-axis circle | *None* | (cm) | 0 to Infinity | *None*
| |

kidney, short-axis circle, right | right kidney SACircl | (cm) | 0 to Infinity | *None*
| |

kidney, short-axis HGT | *None* | (cm) | 0 to Infinity | *None*
| |

kidney, short-axis HGT, right | right kidney SAHGT | (cm) | 0 to Infinity | *None*
| |

kidney, short-axis LGT | *None* | (cm) | 0 to Infinity | *None*
| |

kidney, short-axis WDT | *None* | (cm) | 0 to Infinity | *None*
| |

kidney, short-axis WDT, right | right kidney SAWDT | (cm) | 0 to Infinity | *None*
| |

L-Lactate | L-Lactate | (mg/dL) | 0 to 100 | *None*
| |

lactate | lactate | (mmol/L) | 1 to 50 | *None*
| |

lactate dehydrogenase | lactate dehydrogenas | (U/L) | 0 to Infinity | *None*
| |

latency | latency | (sec) | 0 to 90 | UC Davis - Morris Water Maze | |

lean body mass | *None* | (g) | -Infinity to Infinity | *None*
| |

lean tissue mass | *None* | (g) | -Infinity to Infinity | *None*
| |

lean tissue, % | % lean mass | (%) | 0 to 100 | *None*
| |

left atrial end diastolic area | LAEDA | (mm²) | -Infinity to Infinity | *None*
| |

left atrial end systolic area | LAESA | (mm²) | -Infinity to Infinity | *None*
| |

left atrial fractional area change, % | LAFAC | (%) | -Infinity to Infinity | *None*
| |

left atrial pressure | *None* | (mmHg) | -Infinity to Infinity | *None*
| |

left ventricle interior diameter, end systoloic | LVID-end systoloic | (mm) | 0 to Infinity | *None*
| |

left ventricle anterior wall thickness, end diastolic | LVAWT-end diastolic | (mm) | 0 to Infinity | *None*
| |

left ventricle chamber diameter end diastolic | *None* | (mm) | -Infinity to Infinity | *None*
| |

left ventricle chamber diameter end systolic | *None* | (mm) | -Infinity to Infinity | *None*
| |

left ventricle interior diameter, end diastolic | LVID-end diastolic | | 0 to Infinity | *None*
| |

left ventricle internal diameter end-diastole | *None* | (cm) | 0 to Infinity | *None*
| |

left ventricle internal diameter end-systole | *None* | (cm) | 0 to Infinity | *None*
| |

left ventricle mass | *None* | (g) | 0 to Infinity | *None*
| |

left ventricle posterior wall thickness end diastolic | LVPWT-end diastolic | (mm) | -Infinity to Infinity | *None*
| |

left ventricle posterior wall thickness end systolic | LVPWT-end systolic | (mm) | -Infinity to Infinity | *None*
| |

left ventricle posterior wall thickness end-diastole | LVPWT-end diaastole | (cm) | 0 to Infinity | *None*
| |

left ventricle posterior wall thickness end-systole | LVPWT-end systole | (cm) | 0 to Infinity | *None*
| |

left ventricle septal wall thickness end-diastole | LVSWT-end diastole | (cm) | 0 to Infinity | *None*
| |

left ventricle septal wall thickness end-systole | LVSWT-end systole | (cm) | 0 to Infinity | *None*
| |

left ventricle septum wall thickness end diastolic | LVSWT-end diastole | (mm) | -Infinity to Infinity | *None*
| |

left ventricle septum wall thickness end systolic | LVSWT-end systolic | (mm) | -Infinity to Infinity | *None*
| |

left ventricular minute work | LV Minute work | (mEq/L) | -Infinity to Infinity | *None*
| |

leptin | *None* | (ng/dl) | -Infinity to Infinity | *None*
| |

leptin (RIA) | Leptin | | 0 to Infinity | *None*
| |

leucine | *None* | | 0 to Infinity | *None*
| |

leucine appearance reciprocal model rate | *None* | | 0 to Infinity | *None*
| |

leucine disappearance rate | *None* | | 0 to Infinity | *None*
| |

leucine, blood, arterial | *None* | | 0 to Infinity | *None*
| |

Leukemia inhibitory factor | LIF | (pg/ml) | 0 to Infinity | *None*
| |

linoleate, tissue | linoleate (tissue) | (mg/g tissue) | -Infinity to Infinity | *None*
| |

lipids, blood | *None* | (mg/dL) | 0 to Infinity | *None*
| |

lipids, tissue | lipids tissue | (%) | 0 to Infinity | *None*
| |

lipopolysaccharide binding protein (LBP) concentration | LBP conc | (µg/ml) | 0 to Infinity | UC Davis - Lipoprotein Binding Protein (LBP)-Endotoxemia Assay | |

lipoprotein, intermediate density | *None* | | 0 to Infinity | *None*
| |

lipoproteins, alpha | *None* | (%) | -Infinity to Infinity | *None*
| |

lipoproteins, beta | *None* | (%) | -Infinity to Infinity | *None*
| |

lipoproteins, LDL | *None* | | 0 to Infinity | *None*
| |

lipoproteins, pre-beta | *None* | (%) | -Infinity to Infinity | *None*
| |

liver mass | Liver Wt | (g) | 0 to 6 | *None*
| |

LPS-induced CXC chemokine | LIX | (pg/ml) | 0 to Infinity | *None*
| |

lymph flow | lymph flow | (ml/hr) | -Infinity to Infinity | *None*
| |

Lysine | *None* | | 0 to Infinity | *None*
| |

Macrophage colony stimulating factor | M-CSF | (pg/ml) | 0 to Infinity | *None*
| |

macrophage colony stimulating factor, granulocyte | GM-CSf | (pg/ml) | -Infinity to Infinity | *None*
| |

Macrophage inflammatory protein 2-alpha (CXCL2) | MIP-2/RANTES | (pg/ml) | 0 to Infinity | *None*
| |

Macrophage inflammatory protein 3-alpha (CCL20) | MIP-3a | (pg/ml) | 0 to Infinity | *None*
| |

Macrophage inflammatory protein 3-beta (CCL19) | MIP-3ß | (pg/ml) | 0 to Infinity | *None*
| |

Macrophage inflammatory protein alpha (CCL3) | MIP-1a | (pg/ml) | 0 to Infinity | *None*
| |

Macrophage inflammatory protein beta (CCL4) | MIP-1ß | (pg/ml) | 0 to Infinity | *None*
| |

Macrophage-derived chemokine (CCL22) | MDC | (pg/ml) | 0 to Infinity | *None*
| |

magnesium | *None* | (mEq/L) | -Infinity to Infinity | *None*
| |

mammary gland mass | Mammary wt | (g) | 0 to 3 | *None*
| |

maze errors | maze errors | | 1 to 15 | UC Davis - Radial Arm Water Maze | |

meal duration (Avg) - Active Eating Time | avg meal dur AET | (sec) | 0 to Infinity | *None*
| |

meal duration (total) | total meal duration | (sec) | 0 to Infinity | *None*
| |

meal duration, average dark | avg dark-meal dur | (sec) | 0 to Infinity | *None*
| |

meal duration, average light | avg light-meal dur | (sec) | 0 to Infinity | *None*
| |

meal size (Avg) | avg meal size | (g) | 0 to Infinity | *None*
| |

meal size, average dark | avg dark-meal size | (g) | 0 to Infinity | *None*
| |

meal size, average light | avg light-meal size | (g) | 0 to Infinity | *None*
| |

meals, number | num meals | | -Infinity to Infinity | *None*
| |

meals, number dark | dark-num meals | | -Infinity to Infinity | *None*
| |

meals, number light | light-num meals | | 0 to Infinity | *None*
| |

mesangial index | PAS | (%PAS/glom) | 0 to 100 | *None*
| |

methionine | *None* | | 0 to Infinity | *None*
| |

Monocyte chemotactic protein-1 (CCL2) | MCP-1 | (pg/ml) | 0 to Infinity | *None*
| |

Monocyte chemotactic protein-5 (CCL12) | MCP-5 | (pg/ml) | 0 to Infinity | *None*
| |

Monokine induced by gamma interferon (CXCL9) | MIG | (pg/ml) | 0 to Infinity | *None*
| |

muscle mass, skeletal | skeletal muscle weig | (g) | 0 to 3 | *None*
| |

NEFA | FFA | | -Infinity to Infinity | *None*
| |

NEFA oxidation | *None* | (umol/min/g) | -Infinity to Infinity | *None*
| |

NEFA oxidation, free | FFA OX | (µMol/min/g) | -Infinity to Infinity | *None*
| |

NEFA, arterial | *None* | | 0 to Infinity | *None*
| |

NEFA, in chylomicrons | FFA in CM | (% wt/wt) | -Infinity to Infinity | *None*
| |

NEFA, plasma | *None* | | -Infinity to Infinity | *None*
| |

NEFA, plasma, arterial | apNEFA | | -Infinity to Infinity | *None*
| |

NEFA, plasma, arterial, clamp | *None* | | -Infinity to Infinity | *None*
| |

NEFA, plasma, arterial, fatty acids | *None* | | -Infinity to Infinity | *None*
| |

NEFA, short-chain | *None* | (µg/mg) | 0 to Infinity | *None*
| |

neointimal hyperplasia | Neo Hyperplasia | (µm²) | 0 to Infinity | *None*
| |

non-esterified free fatty acids | NEFA | (µmol/l) | 0 to Infinity | *None*
| |

norepinephrine, plasma, arterial | *None* | | 0 to Infinity | *None*
| |

octanoate oxidation | OCT OX | (µMol/min/g) | -Infinity to Infinity | *None*
| |

oleate, tissue | oleate (tissue) | (mg/g tissue) | -Infinity to Infinity | *None*
| |

osmolality | *None* | (fL) | -Infinity to Infinity | *None*
| |

oxygen consumption | VO2 | (O2/kg/hr) | -Infinity to Infinity | *None*
| |

oxygen consumption (Dark Period) | VO2-D | (O2/kg/hr) | -Infinity to Infinity | *None*
| |

oxygen consumption (Light Period) | VO2-L | (O2/kg/hr) | -Infinity to Infinity | *None*
| |

palmitate, TG-bound new | TG-bound plamitate n | (umol new/g tissue) | -Infinity to Infinity | *None*
| |

palmitate, TG-bound total | TG-bound palmitate t | (umol total/g tissue) | -Infinity to Infinity | *None*
| |

palmitate, TG-bound, newly sythesized | TG-bound palmitate N | (%) | 0 to 100 | *None*
| |

palmitate, tissue | palmitate (tissue) | (mg/g tissue) | -Infinity to Infinity | *None*
| |

PEPCK | *None* | (µMol/min/g) | -Infinity to Infinity | *None*
| |

Permeability | Ki | (min^-1) | 0 to 1 | *None*
| |

phenylalanine | *None* | | 0 to Infinity | *None*
| |

phenylalanine appearance in blood rate | *None* | | 0 to Infinity | *None*
| |

phenylalanine disappearance rate | *None* | | 0 to Infinity | *None*
| |

phenylalanine, blood, arterial | *None* | | 0 to Infinity | *None*
| |

phosphate, blood | *None* | (mg/dL) | 0 to Infinity | *None*
| |

phosphate, blood, inorganic | blood inorganic phos | (mg/dL) | 0 to Infinity | *None*
| |

phosphate, urine | urine inorganic phos | (mg/dL) | 0 to Infinity | *None*
| |

Phosphatidyl choline | *None* | (µg/mg) | 0 to Infinity | *None*
| |

phosphatidyl ethanolamine | *None* | (µg/mg) | 0 to Infinity | *None*
| |

Phosphatidyl serine | *None* | (µg/mg) | 0 to Infinity | *None*
| |

phosphoenolpyruvate | *None* | (µMol/min/g) | -Infinity to Infinity | *None*
| |

Phosphoenolpyruvate carboxykinase flux rate | PEPCK FR | | -Infinity to Infinity | *None*
| |

phosphoenolpyruvate flux rate | PEP FR | | -Infinity to Infinity | *None*
| |

phosphoenolpyruvate fraction | PEP fraction | | -Infinity to Infinity | *None*
| |

phospholipid | *None* | (mg/dL) | -Infinity to Infinity | *None*
| |

phospholipid fatty acids | *None* | (%) | 0 to 100 | *None*
| |

phospholipids, chylomicrons | PL-CM | (% wt/wt) | -Infinity to Infinity | *None*
| |

potassium, blood | *None* | | 0 to Infinity | *None*
| |

potassium, urine | urine postassium | (µmol/l) | 0 to Infinity | *None*
| |

pressure development, maximal rate | *None* | | -Infinity to Infinity | *None*
| |

Prolactin | PRL | (ng/ml) | 0 to Infinity | *None*
| |

proline | *None* | (µmol/l) | -Infinity to Infinity | *None*
| |

protein | *None* | (g/dL) | -Infinity to Infinity | *None*
| |

Protein Carbonyl | Protein Carbonyl | (nmol/ml) | 0 to 1000 | *None*
| |

Protein Carbonyl - protein | P Carbonyl - protein | (nmol/mg) | 0 to 1000 | *None*
| |

protein, chylomicrons | Protein-CM | (% wt/wt) | -Infinity to Infinity | *None*
| |

protein, total blood | *None* | | 0 to Infinity | *None*
| |

pulse | *None* | (bpm) | 0 to Infinity | *None*
| |

pyruvate cycling flux rate | PC FR | | -Infinity to Infinity | *None*
| |

pyruvate oxidation | PYRV OX | (ng/ml) | -Infinity to Infinity | *None*
| |

relaxation, maximal rate | *None* | | -Infinity to Infinity | *None*
| |

Resistin | *None* | (ng/ml) | -Infinity to Infinity | *None*
| |

Respiratory Control | RC | | -Infinity to Infinity | Evaluation of Mitochondrial Function | |

respiratory exchange ratio | RQ | | -Infinity to Infinity | *None*
| |

respiratory exchange ratio (Dark Period) | RER-D | | -Infinity to Infinity | *None*
| |

respiratory exchange ratio (Light Period) | RER-L | | 0 to Infinity | *None*
| |

respiratory exchange ratio, maximum | RQ-Max | (AU) | 0.6 to 1.2 | *None*
| |

respiratory exchange ratio, minimum | RQ-Min | (AU) | 0.6 to 1.2 | *None*
| |

Rg, adipose | *None* | (umol/100g/min) | 0 to Infinity | *None*
| |

Rg, brain | *None* | (umol/100g/min) | 0 to Infinity | *None*
| |

Rg, diaphragm | *None* | (umol/100g/min) | 0 to Infinity | *None*
| |

Rg, gastrocnemeous | *None* | (umol/100g/min) | 0 to Infinity | *None*
| |

Rg, heart | *None* | (umol/100g/min) | 0 to Infinity | *None*
| |

Rg, soleus | *None* | (umol/100g/min) | 0 to Infinity | *None*
| |

Rg, vastus lateralis | *None* | (umol/100g/min) | 0 to Infinity | *None*
| |

Sample Weight | sample weight | (mg) | -Infinity to Infinity | *None*
| |

satiety ratio | satiety ratio | | 0 to Infinity | *None*
| |

satiety ratio, dark | dark-satiety ratio | | -Infinity to Infinity | *None*
| |

satiety ratio, light | light-satiety ratio | | 0 to Infinity | *None*
| |

serines | *None* | | 0 to Infinity | *None*
| |

serum glutamic pyruvic transaminase | *None* | | 0 to Infinity | *None*
| |

sodium, blood | *None* | | 0 to Infinity | *None*
| |

sodium, urine | urine sodium | (µmol/l) | 0 to Infinity | *None*
| |

Somatostatin | Somatostatin | (pg/ml) | -Infinity to Infinity | *None*
| |

sphingomyelin | *None* | (µg/mg) | 0 to Infinity | *None*
| |

sterate | sterate (tissue) | (mg/g tissue) | -Infinity to Infinity | *None*
| |

sterol synthesis | *None* | | -Infinity to Infinity | *None*
| |

Stomach Mass | Stomach Mass | (g) | 0 to 5 | *None*
| |

Superoxide Dismutase Activity | SOD Actvity | (u/ml) | 0 to 5000 | *None*
| |

Superoxide Dismutase Activity - protein | SOD Activity - prot | (U/mg protein) | 0 to 5000 | *None*
| |

TAQ | A | | -Infinity to Infinity | *None*
| |

TCA cycle flux | VTCA | (µMol/min/g) | -Infinity to Infinity | *None*
| |

temperature, body | body temp | (°C) | 25 to 45 | *None*
| |

temperature, environmental | ENV TEMP | (°C) | 3 to 40 | *None*
| |

Thioredoxin | Trx-protein | (ng/mg) | 0 to 10000 | *None*
| |

Thioredoxin Reductase Activity | TrxR-protein | (umol/min/mg) | 0 to 10 | *None*
| |

threonine | *None* | | 0 to Infinity | *None*
| |

Thrombopoeitin | THPO | (pg/ml) | 0 to 10000 | UC Davis - ELISA Protocol | |

Thymus and activation-regulated (CCL17) | TARC | (pg/ml) | 0 to Infinity | *None*
| |

Thyroid-stimulating hormone | TSH | (ng/ml) | 0 to Infinity | *None*
| |

Thyrotropin-releasing hormone | TRH | (pg/ml) | 0 to Infinity | *None*
| |

Thyroxine | T4 | (ng/ml) | 0 to Infinity | *None*
| |

time in platform/border zone | time in zone | (sec) | 0 to 90 | UC Davis - Morris Water Maze | |

Time to Peak Pressure | *None* | (10^3/mm3) | -Infinity to Infinity | *None*
| |

tissue area | tissue area | (cm²) | -Infinity to Infinity | *None*
| |

Tissue-inhibitor of metalloproteinases | TIMP-1 | (pg/ml) | 0 to Infinity | *None*
| |

total activity | *None* | | 0 to Infinity | *None*
| |

total body weight | *None* | (g) | -Infinity to Infinity | *None*
| |

total distance | TD | (m) | 0 to 50000 | *None*
| |

total tissue mass | TTM | (g) | -Infinity to Infinity | *None*
| |

Transforming growth factor beta 1 | TGF-B1 | (ng/ml) | 0 to 1000 | *None*
| |

triglyceride in LDL and VLDL | TG in LDL/VLDL | (mg/dL) | 0 to 2000 | *None*
| |

triglyceride pool enrichment | TG POOL | | -Infinity to Infinity | *None*
| |

triglyceride remaining in intestinal lumen | TG in IL | (%) | -Infinity to Infinity | *None*
| |

triglyceride remaining in intestinal mucosa | TG in IM | (%) | -Infinity to Infinity | *None*
| |

triglyceride transported in lymph | TG in Lymph | (%) | -Infinity to Infinity | *None*
| |

triglyceride, CM | TG in CM | (mg/dL) | 0 to 10000 | *None*
| |

triglyceride, fatty acids | TGFA | (%) | 0 to 100 | *None*
| |

triglyceride, fractional clearance rate | TG FCR | (min) | -Infinity to Infinity | *None*
| |

triglyceride, HDL | TG in HDL | (mg/dL) | -Infinity to Infinity | *None*
| |

triglyceride, hepatic uptake | Hepatic TG uptake | (% wt/wt) | -Infinity to Infinity | *None*
| |

triglyceride, LDL | TG in LDL | (mg/dL) | -Infinity to Infinity | *None*
| |

triglyceride, newly synthesized | new triglyceride | (%) | 0 to 100 | *None*
| |

triglyceride, splenic uptake | Splenic TG uptake | (U/L) | -Infinity to Infinity | *None*
| |

triglyceride, TG-bound new | TG-bound triglycerid | (umol new/g tissue) | -Infinity to Infinity | *None*
| |

triglyceride, TG-bound total | TG-bound triglycerid | (umol total/g tissue) | -Infinity to Infinity | *None*
| |

triglyceride, vLDL | TG in VLDL | (mg/dL) | -Infinity to Infinity | *None*
| |

triglycerides | TG | (mg/dL) | -Infinity to Infinity | *None*
| |

triglycerides in organ through extraction & determination | *None* | (U/L) | -Infinity to Infinity | *None*
| |

triglycerides, tissue | TG (tissue) | (mg/g tissue) | -Infinity to Infinity | *None*
| |

Triiodothyronine | T3 | (pg/ml) | 0 to Infinity | *None*
| |

Troponin I (cardiac) | Troponin I - cardiac | (ng/ml) | 0 to 1000 | *None*
| |

Troponin T | Troponin T | (pg/ml) | 0 to 1000 | *None*
| |

Tumor necrosis factor alpha | TNFa | (pg/ml) | 0 to Infinity | *None*
| |

tyrosines | *None* | | 0 to Infinity | *None*
| |

unesterified cholesterol | *None* | (µg/mg) | 0 to Infinity | *None*
| |

unesterified fatty acids | *None* | (µg/mg) | 0 to Infinity | *None*
| |

urea nitrogen, blood | BUN | (mg/dL) | 0 to Infinity | *None*
| |

urine output | urine output | (ml) | -Infinity to Infinity | *None*
| |

urine pH | urine pH | | 0 to 14 | *None*
| |

valine | *None* | | 0 to Infinity | *None*
| |

Vascular endothelial growth factor | VEGF | (pg/ml) | 0 to Infinity | *None*
| |

VCO2 (Dark) | VCO2-D | (CO2/kg/hr) | 0 to Infinity | *None*
| |

VCO2 (Light) | VCO2-L | (CO2/kg/hr) | 0 to Infinity | *None*
| |

VCO2 30 Min Exercise | *None* | | 0 to Infinity | *None*
| |

VCO2 basal | *None* | | 0 to Infinity | *None*
| |

VCO2 exhaustion | *None* | | 0 to Infinity | *None*
| |

VCO2 max | *None* | | 0 to Infinity | *None*
| |

VCO2 rate | VCO2 rate | (ml/hr/kg) | 0 to Infinity | *None*
| |

Velocity run | Velocity run | (m/min) | 0 to 50 | *None*
| |

VO2 (Dark) | VO2-D | (O2/kg/hr) | 0 to Infinity | *None*
| |

VO2 (Light) | VO2-L | (O2/kg/hr) | 0 to Infinity | *None*
| |

VO2 30 min exercise | *None* | | 0 to Infinity | *None*
| |

VO2 basal | *None* | | 0 to Infinity | *None*
| |

VO2 Exhaustion | *None* | | 0 to Infinity | *None*
| |

VO2 max | *None* | | 0 to Infinity | *None*
| |

VO2 rate | VO2 rate | (ml/hr/kg) | 0 to Infinity | *None*
| |

VO2, maximum | *None* | | -Infinity to Infinity | *None*
| |

water intake | water intake | (ml/kg/hr) | 0 to 4 | *None*
| |

wheel running day | *None* | | 0 to Infinity | *None*
| |

Work Duration | *None* | (min) | 0 to Infinity | *None*
| |

WR max | *None* | | 0 to Infinity | *None*
| |